





TRACE ELEMENT ANALYSIS OF BIOLOGICAL SAMPLES FROM 










submitted in partial fulfillment of the requirements for the degree of 
 
 




Discipline of Optics and Imaging 
College of Health Sciences 








































I, Cassandra Soobramoney declare that: 
(i) The research reported in this dissertation, except where otherwise indicated is my    
original work. 
 (ii) This dissertation has not been submitted for any degree or examination at any other 
 university. 
 (iii) This dissertation does not contain other person’s data, pictures, graphs or other 
 information, unless specifically acknowledged as being sourced from other persons. 
(iv) This dissertation does not contain other persons writing, unless specifically 
acknowledged as being sourced from other researchers.  Where other sources have been 
quoted, then: 
a) Their words have been rewritten but the general information attributed by them has 
been referenced. 
 b) Where their exact words have been used their writing had been placed inside 
 quotation marks and referenced. 
 (v) Where I have reproduced a publication of which I am an author, co-author, I have 
 indicated in detail which part of the publication was actually written by myself alone 
 and have fully referenced such publications. 
 (vi) This dissertation does not contain text, graphics, or tables copied and pasted from 
 the internet, unless specifically acknowledged and the source being detailed in the 
 dissertation and the reference sections.                  
Signed :                                     Date: 
                           31/10/16 








To my late grandma Krishnavalli Naidoo 
 
The epitome of a beautiful soul 































 C Soobramoney, K Maduray, J Moodley, R Moodley and T Naicker (2016). Elemental 
analysis of nails from normotensive and pre-eclamptic Black South African women: A 
clinical study. Journal of Obstetrics and Gynecology. Submitted-Manuscript ID: 2016-
OG-18459 
 
 K Maduray, J Moodley, C Soobramoney, R Moodley and T Naicker (2016).  Elemental 
analysis of serum and hair from pre-eclamptic South African women. Journal of Trace 




PRESENTATION AT NATIONAL CONFERENCES 
 
 C Soobramoney, K Maduray, J Moodley, R Moodley and T Naicker (2016). Trace 
Element analysis of nails in normotensive and pre-eclamptic Black South African 



















This study was funded by: 
 
 College of Health Science Masters Scholarship 
































I wish to express my sincerest gratitude to:   
 
 Professor T Naicker, Professor J Moodley and Dr K Maduray for all the support and 
supervision that enabled me to grow as a researcher; 
 Optics and Imaging Centre, DDMRI, College of Health Sciences, where the study was 
conducted; 
 Dr R Moodley, for her vast knowledge of chemistry that aided us in broadening our 
understanding; 
 Ms Nomfundo Mahlangeni for all her help with running the inductively coupled plasma-
optical emission spectrometer; 
 Ms Zinhle Mkhize, the research nurse for collection of study samples; 
 Dr David Ofusori, for sample digestion; 
 My mom, for always encouraging me to be the best that I can I be. Your strength and 
wisdom brightens any day; you are truly my hero; 
 And my incredible family, for always supporting and believing in me, thank you for 


















TABLE OF CONTENTS 
 









List of abbreviation ………………………………………………………. IX 
List of tables…………………………………………………………………. X  
Abstract……………………………………………………………………… XI 
 
CHAPTER 1………………………………………………………………... 1 
  
Background and Literature……………………………………………….. 2 
1.1.   Pre-eclampsia…………………………………………………………………. 2 
1.1.1. Clinical Features of Pre-eclampsia………………………………………… 2 
1.1.2. Risk Factors………………………………………………………………... 3 
1.1.3. Prevention and Management………………………………………………. 3 
1.1.4. Vitamins and Minerals…………………………………………………….. 5 
1.2.       The Role of Macro and Trace Elements in Pregnancy and Pre-eclampsia… 5 
1.2.1. Zinc………………………………………………………………………... 5 
1.2.2. Iron………………………………………………………………………… 6 
1.2.3. Copper……………………………………………………………………... 6 
1.2.4. Magnesium………………………………………………………………… 7 
1.2.5. Calcium……………………………………………………………………. 7 
1.2.6. Selenium…………………………………………………………………… 7 
1.2.7. Manganese…………………………………………………………………. 8 
1.2.8. Other Beneficial Trace Elements………………………………………….. 8 
VIII 
 
1.2.9. Lead………………………………………………………………………… 9 
1.2.10. Cadmium…………………………………………………………………… 9 
1.2.11. Other Harmful Trace Elements…………………………………………….. 9 
1.3. Aims and Objectives…………………………………………………………… 9 
 
CHAPTER 2……………………………………………………………..  11 
 
Manuscript 1……………………………………………………………………..  11 
 
Elemental analysis of nails from normotensive and pre-eclamptic Black  
South African women: A clinical study…………………………………………  13 
 
CHAPTER 3……………………………………………………………..  27 
 
Manuscript 2……………………………………………………………………..  27 
 
Elemental Analysis of Serum and Hair from Pre-eclamptic South African 
Women…………………………………………………………………………....  28 
 
CHAPTER 4………………………………………………………………  43 
 
Synthesis and Conclusion…………………………………………………………  44 
 
CHAPTER 5……………………………………………………………....  48 
 
References………………………………………………………………………...  49 
 













As  Arsenic 
Ca  Calcium 
Mg  Magnesium 
Se  Selenium 
Pb  Lead 
Ni   Nickel 
Cu  Copper 
Co  Cobalt 
Zn  Zinc 
Mn  Manganese 
Cr  Chromium 
Fe  Iron 
Cd  Cadmium 
PE  Pre-eclampsia 






















2.1  Experimental values and certified values (g/g, dry, mass , median  
S.E.M ,95% confidence interval, n = 4) for the certified reference material 
(White clover – BCR 402) 
 
18 
2.2 Clinical data of normotensive (n = 33) and pre-eclamptic (n = 33) women 
 
19 
   
2.3 Dietary information of normotensive (n = 33) and pre-eclamptic (n = 33) 
women 
20 
   
2.4 Elemental concentrations (median  S.E.M) in nail samples of 
normotensive (n = 33) and pre-eclamptic (n = 33) patients 
21 









Demographic and clinical data of normotensive control and pre-eclamptic 
groups (n = 66) 
33 
3.2 The levels of different elements in hair samples from the pre-eclampsia 
and control groups (n = 66) 
 
34 
3.3 Serum levels of different elements across study groups (n = 66) 
 
35 
3.4 Correlations between hair elemental levels (µg/g), maternal and fetal 
parameters in the pre-eclamptic group (n = 43) 
 
36 
3.5 Correlations between serum elemental levels (mg/l), maternal and fetal 







Elemental deficiency is a causative factor in a number of pregnancy related conditions such as 
pre-eclampsia (PE). Its greatest impact is in developing countries, where the dietary intake of 
essential minerals and vitamins are poor. Therefore, the main aim of this study was to compare 
the concentrations of thirteen different trace elements in nail samples from pre-eclamptic and 
normotensive women. Also, this study aimed to compare the nail concentrations of these thirteen 
different trace elements to hair and serum concentrations in pre-eclamptic and normotensive 
women. The selected study site was a large regional hospital in Durban, Kwa-Zulu Natal. Nail 
clippings were sampled from normotensive (n = 33) and pre-eclamptic (n = 33) pregnant women. 
Nail (0.02 g), pubic hair (0.01 g) and serum (0.5 mL) samples were processed using the wet acid 
digestion method. Each of the digested samples were analyzed for  Zinc (Zn), Selenium (Se), 
Lead (Pb), Nickel (Ni), Magnesium (Mg), Manganese (Mn), Iron (Fe), Copper (Cu), Calcium 
(Ca), Cobalt (Co), Cadmium (Cd), Chromium (Cr) and Arsenic (As) using the inductively 
coupled plasma-optical emission spectrometry.  
 
There was a significant decrease in the nail concentration of Co (p = 0.0001), Mn (p = 0.022) and 
Cd (p = 0.004) in the PE group. Also in the pre-eclamptic group, pubic hair samples yielded a 
significant decrease in Co (p = 0.02), Cr (p = 0.01) and Zn (p = 0.05) while Co (p = 0.0001), Mn 
(p = 0.03), Cu (p = 0.001), Ca (p = 0.02), Mg (p = 0.0001), Se (p = 0.001) and Zn (p = 0.01) was 
significantly lower as compared to the normotensive group. Significantly decreased levels of Co 
were observed across all three biological samples whilst decreased levels of Mn were only 
observed in the serum and nail samples in the pre-eclamptic compared to the normotensive group. 
In conclusion, these dual studies observed a possible link between pre-eclampsia and macro- as 
well as micronutrients. Therefore, more extensive research on the role of these elements may aid 
in reducing the risk of developing PE. Also, it may be used as a potential indicator or biomarker 







































Background and Literature 
 
1.1.Pre-eclampsia 
Pre-eclampsia (PE) is a relatively common condition that affects 3-10% of pregnancies 
worldwide, and it is one of the leading causes of fetal and maternal morbidity and mortality. 
The occurrence of maternal and fetal morbidity in developed countries is less common due to 
patient access to better health facilities (Jeyabalan, 2013), and more frequent in middle to low 
income countries (i.e. sub-Saharan Africa and the Indian subcontinent) (Dadelszen et al., 
2012). Studies have shown that PE affects various organ systems. Therefore, determining the 
precise etiology of this condition has been a major challenge and remains unknown 
(Jeyabalan, 2013).  
 
1.1.1. Clinical Features of Pre-eclampsia 
Pre-eclampsia can be classified as either early or late onset. Early onset PE refers to 
occurrence of the condition before or at 33 weeks of gestation while late onset PE occurs at or 
after 34 weeks of gestation  (Madazli et al., 2014). The occurrence of PE is more common 
during the second half of a pregnancy, with a new onset of hypertension and proteinuria. The 
main clinical features of PE are a systolic blood pressure of  140 mmHg and a diastolic 
blood pressure of  90 mmHg as well as the presence of proteinuria ( 300 mg) in a 24 hr 
urine sample obtained from pregnant women (Young et al., 2010). It is often characterized as 
either mild or severe, depending on the clinic features and complications that may occur. The 
characteristics of severe PE includes; a blood pressure of  160 mmHg systolic and/or  110 
mmHg diastolic, renal and hepatic dysfunction as well as placental abruption and fetal growth 
restrictions (Jeyabalan, 2013).  
 
In pre-eclampsia, the maternal uterine spiral arterioles arteries fail to convert into wide 
sinusoids. Also, the trophoblastic invasion of the uterine vessel is incomplete which gives rise 
to restricted blood supply and this causes feto-placental hypoxia. Subsequently, placental 
factors are released to compensate for the comprised blood flow. These placental factors 
include angiogenic agents, cytokines, products of lipid peroxidation, autoantibodies and 
placental cell debris. One of the contributing factors of endothelial dysfunction is an ischemic 
placenta which alters the balance between circulating levels of angiogenic and anti-
angiogenic growth factors. These growth factors include vascular endothelial growth factor 
(VEGF) and soluble fms-like tyrosine kinase-1 (sFlt-1). SFlt-1 has been shown to bind to and 
inhibit the VEGR activity. Both sFlt-1 and endoglin (also an ant-angiogenic factor), have 
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been implicated in the pathogenesis of pre-eclampsia indicating elevated levels in the 
maternal circulation before the onset of the disease. Pre-eclampsia has been suggested to be 
an inflammatory response to pregnancy. An excess of immune complexes is unable to be 
cleared by the maternal immune system, hence they are deposited in the various endothelial 
layers causing pro-inflammatory cytokines and oxidative stress. The maternal oxidative stress 
in turn stimulates further placental apoptosis and necrosis which leads to varying severities of 
pre-eclampsia (Sanjay et al., 2014). If the condition is not properly managed, it could lead to 
the development of eclampsia, which is characterized with severe seizures and the possibility 
of the individual going into a coma (Young et al., 2010). The sudden development of edema 
can also be an indicator of PE, however it is known as a non-specific clinical feature 
(Alghazali et al., 2014).  
 
1.1.2. Risk factors 
Medical conditions such as chronic hypertension, diabetes, renal disease and obesity are 
associated with risks of developing PE and it predisposes both mother and child to 
cardiovascular disease after the pregnancy (Alghazali et al., 2014). Gestational diabetes has 
been thought to be linked to PE with the severity of gestational diabetes being influenced by 
the progressive rate of PE (Shamsi et al., 2013). Furthermore, PE is more common during a 
woman’s first pregnancy however there is an increased risk of the condition in multiparous 
pregnant women and in women who frequently change partners. Also, mild PE has been noted 
in pregnancies involving the delivery of a male child and this may be due to the increased 
levels of testosterones in the body. In addition, studies have shown that a prior abortion 
confers a weak protective effect against PE while a prior pregnancy confers a strong 
protective effect (Shamsi et al., 2013). 
 
A family history of the condition increases the risk of developing severe PE (Young et al., 
2010). Also, one of the major maternal risk factors includes the age of the mother. Some 
studies have shown that women above the age of 35 years have an increased risk of 
developing PE while other studies show that younger women (< 25 years) are more likely to 
develop this disorder. This makes advanced maternal age as well as young maternal age a risk 
factor. It has been observed that women above the age of 40 are two times more likely get the 
disease (Shamsi et al., 2013). Also, researchers have found that the time between pregnancies 
is  a risk factor, with findings showing that women with more than 5 years between 
pregnancies are at a greater risk of developing PE than those who had less than 2 years 
between their pregnancies (Shamsi et al., 2013). Additionally, PE can be considered to be a 
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risk factor for other maternal and fetal complications later on in life. The mother and child 
have an increased risk of having a stroke or developing hypertension while the mother also 
has an increased risk of coronary heart disease (English et al., 2015). It has been noted that 
the timely delivery of the child does not reduce the risk of life altering complications (e.g. 
stroke, renal failure etc) of PE (Dadelszen et al., 2012). 
 
1.1.3. Prevention and Management 
The most common cure for PE is the birth of the baby and delivery of placenta. This indicates 
that the placenta plays a major role in the pathogenesis of PE (Young et al., 2010). The 
management of PE focuses mainly on early detection and delivering the child in a timely 
manner to prevent serious complications and even death (English et al., 2015). There are two 
factors that should be considered at diagnosis before delivery and these include the severity of 
the PE and gestational age of the fetus (Uzan et al., 2011). However, there are drugs available 
to help manage PE, depending on the severity. These include; magnesium sulphate and 
antihypertensive medication such as aspirin and nifedipine.  
 
Magnesium sulphate is used to treat patients with severe PE and it is a well-established drug 
to be used in the reduction of complications from eclampsia for both the mother and fetus. 
However, this treatment must be closely monitored as misuse (i.e. overdose, high 
concentrations) could lead to organ failure (Uzan et al., 2011). Antihypertensive medications 
such as aspirin and nifedipine have been used to treat patients with PE. Studies have shown 
that antiplatelet agents such as aspirin has been effective in preventing PE in women who 
were at moderate to high risk of developing the disease (Bartsch et al., 2016), while 
nifedipine is used to treat severe hypertension during pregnancy and to prevent delivery 
preterm (Uzan et al., 2011).  
 
Another method of managing or maybe even preventing PE is the use of vitamin and mineral 
supplements. Calcium supplementation administered from mid-pregnancy has shown to 
significantly decrease the risk of developing PE especially in women with low calcium (Ca) 
dietary intake. However studies have shown that the use of supplements, especially Ca, 
increases the risk of the myocardial infarctions (Dadelszen et al., 2012). It is currently 
recommended by WHO that calcium supplementation is taken by women before pregnancy 
especially in women who are at high risk for PE and other hypertension disorders (Dadelszen 
et al., 2012). Furthermore, the ingestion of isolated vitamins such as vitamin C and E does not 
confer a protected effect against PE, as opposed to a diet rich in antioxidants. This means that 
a nutrient rich, balanced diet is essential for both the mother and the fetus. A healthy diet can 
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not only reduce the risk of PE but also reduce the severity of this condition as well (Dadelszen 
et al., 2012). 
 
1.1.4. Vitamins and minerals 
Vitamins and minerals play an important role in the development of the growing fetus and the 
overall health of the mother (E.Hassan et al., 2014). Pre-eclampsia, together with other 
conditions such as placental abruption, still birth and low birth weight are considered to be 
linked to or are the result of macro and trace element deficiencies during pregnancy 
(Alghazali et al., 2014). Minerals and elements (i.e. calcium, zinc, iron etc) are usually 
provided by dietary intake during pregnancy. Pregnant women from developing countries are 
likely to have an inadequate dietary intake of these micronutrients due to their poor socio-
economic status. Therefore, nutritional deficiencies are common amongst pregnant women in 
developing countries and this could play a role in the development of PE (Wang et al., 2009). 
 
1.2. The Role of Macro and Trace Elements in Pregnancy and Pre-eclampsia 
Macro and trace elements have been shown to be crucial to the development of the fetus and a 
deficiency of these micronutrients could affect delivery and outcome of a pregnancy as well 
as overall development in childhood and adulthood (Pathak and Kapil, 2004). Certain trace 
elements function as catalytic components in various reactions while others play a vital role in 
the structural function of molecules such as enzymes and hormones (Al-Jameil et al., 2015). 
Interactions between certain trace elements results in their dependency on one another. For 
example, Zn absorption is impaired by iron (Fe) deficiency in the intestinal mucosa while 
copper (Cu) competes with Zn at the intestinal absorption level. The absorption of Cu is 
reduced by increased Zn dietary intake however increased levels of Cu do not impair Zn 
absorption. Essential elements required during pregnancy for maintaining the health of the 
mother and development of the fetus include Ca, Zn, magnesium (Mg), iron (Fe), Cu, 
selenium (Se), manganese (Mn), chromium (Cr) and cobalt (Co). In contrast, toxic elements 
such as lead (Pb), cadmium (Cd) and arsenic (As) can negatively impact fetal growth. The 
deficiency or excess of these elements has been associated with cell damage, fetal growth 
restriction and maternal complications. Therefore, elements such as Zn, Fe and Ca should be 










Zinc plays a major role in the proper development of the brain of the fetus and it also aids the 
mother during labor (Rasthore et al., 2011). The concentration of serum Zn has been reported 
to be decreased in PE as compared to normotensive women (Elind, 2016). Zinc is a cofactor 
of DNA and RNA synthesis as well as various other enzymes.  Zinc deficiency in pregnant 
women can be either mild or severe. Congenital malformation and spontaneous abortions are 
associated with a severe Zn deficiency while low birth weight, intrauterine growth restriction 
(IUGR) and preterm delivery are the outcome of milder forms of Zn deficiency (Awadallah et 
al., 2004).  
 
1.2.2. Iron 
Iron deficiency and anemia are recognized globally as the most common nutritional 
deficiency problem (Awadallah et al., 2004). Iron deficiency can negatively impact the 
growth of the fetus by causing preterm delivery. It can also affect the early life of the child by 
altering the brain biochemistry as well as the development of the brain, furthermore it can 
lead to the development of cardiovascular disease in adulthood (Gambling et al., 2003). 
 
The Fe requirement for an expectant mother increases from 0.8 mg per day in the first 
trimester to 6-7 mg per day in the second trimester in order to ensure proper development of 
the fetus and overall health of the mother. Iron has a particularly important role as it is 
essential for hemoglobin synthesis and the additional production of erythrocytes which are 
required during pregnancy (Allen, 2000). During pregnancy maternal Fe absorption is 
increased. The placenta mediates the transfer of Fe from the mother to fetus for all the unborn 
child’s developmental needs. In PE women, serum iron levels are elevated which results in 
lipid peroxidation and damage to endothelial cells (Elind, 2016). Trials conducted have 
shown that the birth weight of newborns was higher in the mothers who had taken iron 
supplements as compared to non-supplemented pregnancies. Pre-term babies are more likely 
to have developmental problems such as stunted growth and poor Fe stores (Allen, 2000). 
 
1.2.3. Copper 
Copper is involved in the function of many cuproenzymes which are necessary for life 
(Pathak and Kapil, 2004). It is required for the absorption of Fe as it aids in the formation of 
ceruloplasmin which is a Cu carrying protein that plays a role in Fe metabolism (Ozden et al., 
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2015). Copper deficiencies in fetuses have been shown to cause structural and biochemical 
abnormalities (Pathak and Kapil, 2004). Also, studies have shown that the concentration of 
Cu in pregnant women is twice that of normal adults. This suggests that Cu plays an 
important role in maintaining a healthy pregnancy as low levels of this element increases the 
risk of preterm birth and the premature rupture of membranes (Gambling et al., 2003). 
Additionally, increased levels of Cu are associated with PE as it is an important antioxidant 
component required to reduce the effects of oxidative stress (Elind, 2016).  
 
1.2.4. Magnesium 
Trials conducted have shown that women with PE have reduced levels of Mg and Ca in their 
bodies. The treatment of choice is usually magnesium supplementation (Ephraim et al., 
2014). Magnesium is essential to the structure and function of the human body, making it one 
of the most abundant minerals in the body. Approximately 50% of the body’s total Mg is 
located in the bones with majority of the remaining Mg being found in tissues, organs and 
cells. Only a minuscule proportion of Mg is found in the blood stream (Baloch et al., 2012). 
Additionally, Mg plays a significant role in peripheral vasodilation and neurochemical 
transmission (Al-Jameil et al., 2015). In the growing fetus Mg is essential for cell 
multiplication and ensuring a balanced neuro muscular system. This element plays a role in 
proper fetal development and bone formation also acting as a cofactor for various enzymes 
(Baloch et al., 2012). A deficiency of Mg results in an increase in the production of reactive 
oxygen species which is associated with endothelial dysfunction and PE (Elind, 2016). 
 
1.2.5. Calcium 
During pregnancy the maternal requirement of Ca is around 300mg per day (Ritchie and 
King, 2000). It has an important role in water balance of the cells and muscle contraction (Al-
Jameil et al., 2015). Notably, Ca deficiencies in pregnant women can lead to the fetus being 
born prematurely. Thus, calcium supplementation can lead to the prevention of preterm birth 
and the development of PE. There has been evidence to suggest that an excessive amount of 
calcium supplementation may have harmful effects on mother and fetus (Dadelszen and 
Magee, 2014). Calcium supplementation, which does not include dietary Ca, may cause 
postnatal bone demineralization and it has been associated with an increased risk of 
myocardial infarction (Dadelszen and Magee, 2014). A study conducted showed that a low 
dose of Ca supplements decreased the risk of developing PE (Dadelszen and Magee, 2014), 
while another demonstrated that a high intake of dietary Ca increases the likelihood of proper 
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bone development of the infant and it can also prevent bone loss to the mother during 
pregnancy (Hacker et al., 2012).  
 
1.2.6. Selenium 
Selenium activates anticarcinogenic factors and prevents cardiovascular diseases. It stimulates 
the immune system to act antagonistically towards heavy metals such as Pb, Cd etc. Selenium 
also protects cells against genetic damage  (Pieczynska and Grajeta, 2015). During pregnancy 
a Se deficiency can lead to dysfunctions in the nervous system of the fetus as well as neural 
tube defects especially anencephaly rachischisis (a type of birth defect that causes abnormal 
formation of the spinal column). Selenium is essential for preventing insulin resistance and 
promoting proper glucose uptake and the regulation of cellular absorption of glucose 
(Pieczynska and Grajeta, 2015). Low serum Se levels have been observed in women with PE. 
A decrease in selenoprotein production (including endogenous antioxidants) have also been 




Manganese is required for the metabolism of carbohydrates, lipids and proteins as well as for 
various cellular metabolic mechanisms such as protection against lipid peroxidation, making 
it an essential trace element. Studies have shown that the Fe stores in the body affect Mn 
absorption, whereby women with low Fe stores absorb approximately 5% of dietary Mn while 
women with normal Fe, stores approximately 1% of dietary Mn (Wood, 2009). A dietary 
deficiency of Mn can lead to bone abnormalities, abnormal metabolism of carbohydrates and 
lipids as well as congenital ataxia in the newborn child. It may also lead to an individual 
being susceptible to certain diseases such as osteoporosis and epilepsy. In contrast, excess 
exposure to Mn can have neurotoxic effects (Takser et al., 2004). Manganese is classified as 
an important antioxidant component, and a deficiency of this element can result it an increase 
in oxidative decrease which could lead to the development of PE (Ikaraoha et al., 2016). 
 
1.2.8. Other Beneficial Trace Elements 
Another micronutrient involved in glucose uptake is Cr. Chromium acts as a cofactor for 
insulin and may be important for glucose homeostasis. It is found in many different foods 
such as cheese, vegetables, fish etc (Woods et al., 2008). While Co, on the other hand, 
benefits human health as it is part of vitamin B12, and it has been used to treat anemia as it 
induces red blood cell production. Decreased levels of Cr and Co may play a role in the 
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development of PE as these elements cause an increase in oxidative stress, inflammation, 
endothelial dysfunction and even DNA damage (Elind, 2016). While most trace elements are 
beneficial and necessary to the health of pregnant women and their developing fetuses, 
exposure to some trace elements such as As and Cd can have detrimental effects. 
 
 
1.2.9. Lead  
Lead is an environmental contaminant which is used in many products, such as paint on a 
daily basis. It accumulates in soil or dust and can be easily ingested by children leading to 
elevated levels in the blood. Elevated levels of Pb can lead to a decrease in IQ scores, violent 
or aggressive behaviors and even anemia, with these effects being irreversible. Furthermore, 
studies have shown that Pb exposure to pregnant women negatively impacts the 
developmental of the fetus. It could also lead to the abnormal development of vital organs, 
low birth weight and have severe neurological effects (Haman et al., 2015). This toxic metal 
increases oxidative stress thereby increasing the risk of developing PE as this disorder is 
associated with oxidative stress (Haman et al., 2015).  
 
1.2.10. Cadmium 
Cadmium exposure occurs when humans come in contact with foods such as seafood, offals, 
cereals as well as the inhalation of tobacco smoke. Cadmium has a relatively long half-life 
once it has been absorbed, especially in the kidneys (Kippler et al., 2012). Cadmium has been 
shown to negatively impact the development of children as it accumulates in the placenta of 
humans (Kippler et al., 2012). This can lead to reduced size at birth as well as pre-term 
delivery (Nishijo et al., 2002). It has been reported that Cd may impair transport of Zn to the 
fetus as the levels of this element has been shown to be elevated in the placenta of PE women 
when compared to a normotensive population (Kippler et al., 2012).  
 
1.2.11. Other Harmful Trace Elements 
Arsenic is a common environmental pollutant and is also a known carcinogen and neurotoxic 
element.  It has been reported that high levels of arsenic (> 50 ug/L) found in drinking water 
can result in low birth weight pregnancies (Tofail et al., 2009) an this element has been 
shown to be the cause of stillbirths and spontaneous abortion (Ahmad et al., 2001). Oxidative 
stress has been reported to be an essential component of As toxicity. Additionally, nickel (Ni) 
has been shown to have various adverse effects on the health of exposed individuals. These 
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range from skin problems and depression to cancer, heart attacks and even kidney dysfunction 
(Abdulrahman et al., 2012).  
 
1.3. Aims and Objectives 
 
The role of these elements on the development of PE has not been properly established. 
Therefore, the aim of this study is to analyze the concentration of Zn, Fe, Ca, Cu, Cr, Co, Pb, 
Se, As, Mg, Mn, Ni and Cd in the biological samples (nail, hair and serum) of normotensive 
and pre-eclamptic Black South African women.  
 
The specific objectives include quantifying the levels of these elements in the nails (finger 
and toe nails) of the pregnant women using inductively coupled plasma-optical emission 
spectrometry. These results will then be compared to the values obtained for the hair and 
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Objective: To compare the concentrations of thirteen different elements in nail samples from 
pre-eclamptic and normotensive pregnant women.  
Setting: The study site was a regional hospital in Durban, Kwa-Zulu Natal.  
Population: Nail samples were collected from normotensive (n=33) and pre-eclamptic (n=33) 
pregnant women. 
Method: Approximately 0.02 g of nail samples were digested in 70% nitric acid and analyzed 
using inductively coupled plasma-optical emission spectrometry. 
Main Outcome Measures: Analytes of interest were the following essential elements 
calcium (Ca), chromium (Cr), cobalt (Co), copper (Cu), iron (Fe), magnesium (Mg), 
manganese (Mn), nickel (Ni), selenium (Se) and Zinc (Zn) as well as toxic elements, arsenic 
(As), cadmium (Cd) and lead (Pb). 
Results: The levels of Ca (3467.4  197.42 vs. 2897.0  189.82 g/g) and Mg (736.10  
60.98 vs. 694.83  59.36 g/g) were higher in the normotensive compared to the pre-
eclamptic group, however it was not significant. In contrast, the concentration of Cd (3.07  
0.29 g/g) was significantly lower in the pre-eclamptic compared to the normotensive group 
(p = 0.004). Also, there was a significant difference between the normotensive and pre-
eclamptic group for Co (p = 0.0001) and Mn (p = 0.022).  
Conclusion: This study demonstrated significantly lower levels of Cd, Co and Mn in pre-
eclampsia which justifies the need for further research on these elements towards the effective 
management or prevention of pre-eclampsia which could ultimately aid in establishing its 
pathogenesis. 








In pregnancy, macro and trace elements are crucial for various biochemical and metabolic 
processes, which are involved in the development of a healthy fetus. Interactions between the 
various elements allow for appropriate intrauterine fetal development with elements, such as 
Ca, Fe, Zn and Mg being fundamental to fetal growth (Pathak and Kapil, 2004). Certain 
elements also function as catalytic components in these processes or play a vital role in the 
structure and function of molecules such as enzymes and hormones (Al-Jameil et al., 2015). 
Therefore, adopting a balanced diet during pregnancy ensures adequate minerals, macro and 
trace elements for both the mother and fetus. In low and middle income countries (LMIC) an 
insufficient intake of essential nutrients can result in various deficiencies and nutrition related 
conditions in women (Pathak and Kapil, 2004).  
 
Pre-eclampsia, together with other pathological conditions such as placental abruption, 
stillbirth and low birth weight are associated with a deficiency of elements in the body 
(E.Hassan et al., 2014). Notably this may augment the development of pre-eclampsia in 
LMIC such as South Africa. In such populations where Ca intake is low, Ca supplementation 
as part of the antenatal care is recommended for reducing the risk of developing pre-
eclampsia (Dadelszen et al., 2012). However, the ingestion of isolated vitamins such as 
vitamin C and E supplementation does not confer a protected effect against pre-eclampsia, as 
opposed to a diet rich in antioxidant components such as Se, Mn and Zn. Thus a nutrient rich 
dietary intake is not only beneficial for the health of the mother and the fetus but may reduce 
the risk and the severity of pre-eclampsia (Dadelszen et al., 2012). 
 
Unfortunately, there is a paucity of data on the role of essential elements in the development 
pre-eclampsia. Therefore, this study evaluates the concentrations of essential elements 
calcium (Ca), chromium (Cr), cobalt (Co), copper (Cu), iron (Fe), magnesium (Mg), 
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manganese (Mn), nickel (Ni), selenium (Se) and zinc (Zn) as well as toxic elements arsenic 
(As), cadmium (Cd) and lead (Pb) in the nail clippings of Black South African pregnant 





This study was carried out at the Optics and Imaging Centre, University of Kwa-Zulu Natal. 
Following informed consent and institutional ethics approval (BE: 092/16) a total of 66 
pregnant women were recruited from the antenatal clinic of a regional hospital in Durban, 
Kwa-Zulu Natal Province, South Africa. Nail samples were collected from normotensive (n = 
33) and pre-eclamptic pregnant women (n = 33). Pre-eclampsia was clinically defined as 
blood pressure of 140/90 mmHg taken twice at least two hours apart, systolic blood pressure 
of  160 mmHg, a rise of 30 mmHg and 15 of mmHg over baseline values and a proteinuria 
of 1 + (30 – 100 mg/dL) or greater (Amin et al., 2014). Additionally, dietary information of 
all patients was collected via a questionnaire and expressed as a percentage (%) of women 
that consumed the different types of food products. Pregnant women infected with HIV or had 
other medical conditions such as gestational diabetes, epilepsy, chronic asthma, cardiac, 
thyroid and chronic renal diseases were excluded from the study. 
 
Collection and analysis of samples 
Nail samples included both finger and toe-nail clippings, and were obtained using a sterile 
stainless steel nail clipper. Both the certified reference material and nail clippings (0.02 g) 
were digested using the wet acid digestion method (Kuboyama et al., 2005). Samples were 
boiled in 10 mL of nitric acid (HNO3) on a hot plate. Thereafter, the digests were transferred 
to 25 mL volumetric flasks and distilled water was added to reach volume capacity. Digested 
samples were analyzed for As, Ca, Cd, Cr, Co, Cu, Fe, Mg, Mn, Ni, Pb, Se and Zn using an 
inductively coupled plasma-optical emission spectrometer (ICP-OES, Optima TM 5300 DV, 
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USA) and reported as g per gram (g/g), dry matter. Working standards were prepared from 
1000 ppm elemental standards that were supplied by Sigma Aldrich (St Louis, USA) and 
were prepared in 70% HNO3 to match the sample matrix. The three most sensitive analytical 
wavelengths were initially chosen for analysis and the line with minimal spectral 
interferences and maximum analytical performance was finally selected. 
 
Statistical analysis 
The data obtained was analyzed using IBM Statistical Package for the Social Science (PASW 
Statistics, Version 23, IBM Corporation, Cornell, New York). The clinical data was expressed 
as mean  standard deviation (SD), the elemental concentrations were expressed as median  
standard error of mean (S.E.M) and the dietary information was presented as percentages. The 
independent T-test and Mann-Whitney tests were used to determine the p values of the 
parametric and non-parametric data. All data with a p value  0.05 was considered significant. 




The experimental results obtained for the certified reference material (White clover – BCR – 
402, Institute for Reference Materials and Measurements, European Commission, Joint 
Research Centre, Belgium) was compared to the certified values from the Certificate of 
Analysis (Table 1). The investigation showed measured results to be within the acceptable 








Table 1: Experimental values and certified values (g/g, dry, mass , median  S.E.M , 95% confidence 
interval, n = 4) for the certified reference material (White clover – BCR 402) 
Element Certified value Experimental value 
Cr 5.19 5.10  0.170 
Fe 244 237  18.0 
Se 6.70  0.25 6.81  1.40 
Zn 25.2 30.3  6.37 
 
 
Demographic data  
The clinical data of the study population is represented as mean  SD in Table 2. The systolic 
(p = 0.0001) and diastolic (p = 0.0001) blood pressure levels were significantly higher in the 
pre-eclamptic as compared to normotensive group, with values of 155.88  11.98 mmHg and 
99.09  7.27 mmHg, respectively. The maternal age (p = 0.870), body mass index (p = 
0.989), hemoglobin count (p = 0.983), white blood cell count (p = 0.819), red blood cell count 
(p = 0.176) and platelet count (p = 0.084) were similar between the groups. However, baby 
weight was significantly lower in the pre-eclamptic as compared to the normotensive group 
(2.81  0.74 versus 3.30  0.71 kg respectively; p=0.030). A significant negative correlation 
was observed for baby weight and diastolic blood pressure (r = -0.603; p = 0.004) in the pre-
eclamptic group. It should be noted that patients received ferrous sulphate (200 mg), folic 










Table 2: Clinical data of normotensive (n = 33) and pre-eclamptic (n = 33) women 
 Normotensive Pre-eclampsia p-value 
Systolic BP (mmHg) 113.39 14.29 155.88 11.98 *0.0001 
Diastolic BP (mmHg) 69.06 10.12 99.09 7.27 *0.0001 
Proteinuria (+) 0.00 0.00 2.0 0.777 *0.0001 
BMI (kg/m2) 32.29 6.46 32.27 7.60 0.989 
Maternal Age (yrs) 26.14 6.54 26.32 6.31 0.870 
Baby Weight (kg) 3.30 0.71 2.81 0.74 *0.030 
Gestational Age (wks) 35.61 4.89 33.55 5.59 0.069 
HB (g/dL) 10.15 3.47 10.95 1.29 0.983 
WBC (L) 8.60 2.94 8.86 3.48 0.819 
RBC (L) 3.92 0.63 3.64 0.43 0.176 
PLT (L) 184.01 
100.01 
230.70 67.98 0.084 
BP: Blood Pressure; BMI: Body Mass Index; HB: Hemoglobin; WBC: White blood cell; RBC: Red blood cells; PLT: 
Platelet, *Level of significance: (p0.05) 
 
 
Patient dietary information 
The dietary information of the study population is presented in Table 3. The dietary intake of 
fish (p = 0.489) and meat (p = 0.664) were similar between the study groups whilst a 
significant difference in the number of women consuming cheese (p = 0.004), green 










Table 3: Dietary information of normotensive (n = 33) and pre-eclamptic (n = 33) women 






























Coffee 45.45 3.03 24.24 27.27 54.54   45.45 *0.011 
Rooibos 
Tea 
54.54 3.03 15.15 27.27 84.85   15.15 0.173 
Milk 69.70 3.03 21.21 6.06 87.88   12.12 *0.003 
Cheese 69.70 3.03 21.21 6.06 90.91   9.09 *0.004 
Yoghurt 69.70 3.03 24.24 3.03 93.94   6.06 *0.001 
Greens 66.67 3.03 27.27 3.03 87.88   12.21 *0.001 
Fruits 69.70 3.03 27.27  96.97   3.03 *0.0001 
Cereal 72.73 3.03 21.21 3.03 87.88   12.21 *0.0001 
Fish 3.03 36.36 48.48 12.13 6.06 36.36 54.55 3.03 0.489 
Meat 6.06 63.64 18.18 3.03 6.06 78.79 15.15  0.664 
           *Level of significance (p0.05) 
 
Elemental concentrations 
Elemental concentrations are represented as median  S.E.M in Table 4. If present, 
concentrations of As were found to be below the instrument detection limit in both study 
groups. Except for Cr, Fe and Zn, median concentrations of all elements studied were found 
to be higher in the normotensive compared to the pre-eclamptic group. The concentrations of 
Cd (p = 0.004), Co (p = 0.0001) and Mn (p = 0.022) were found to be significantly higher in 
the normotensive compared to the pre-eclamptic group. In both the normotensive and pre-
eclamptic group, concentrations of essential elements were found to be in decreasing order of 
Ca > Fe > Mg > Zn > Cu > Ni > Se > Mn/Cr > Co and concentrations of toxic elements were 
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in decreasing order of Pb > Cd > As. The normotensive and pre-eclamptic groups showed 
significant positive correlations between Ca and Mg (r = 0.745, p = 0.0001 and r = 0.932; p = 
0.0001, respectively) and Zn and Fe (r = 0.746, p = 0.0001 and r = 0.386, p = 0.026, 
respectively).  
 
Table 4: Elemental concentrations (median  S.E.M) in nail samples of normotensive (n = 33) and pre-
eclamptic (n = 33) patients 
  Normotensive Pre-eclampsia  P value 
Ca  3467.4 197.42 2897.0 189.82  0.133 
Cd  3.07 0.29 1.56 0.40  *0.004 
Cr  5.21 1.57 5.24 12.42  0.331 
Co  2.75 0.32 ND  *0.0001 
Mg  736.10 60.98 694.83 59.36  0.523 
Mn  6.96 1.28 3.70 0.76  *0.022 
Fe  284.01 165.36 292.82 51.52  0.517 
Cu  54.18 278.72 43.60 23.57  0.125 
Pb  51.70 25.16 36.75 23.15  0.352 
Se  10.11 1.51 9.81 1.47  0.831 
Ni  13.62 3.43 11.83 2.44  0.172 
Zn  205.98 63.88 296.79 34.19  0.394 
As: Arsenic, Ca: Calcium, Cd: Cadmium, Cr: Chromium, Co: Cobalt, Mg: Magnesium, Mn: Manganese, Fe: Iron, Cu: 












This study demonstrates elevated levels of Ca and Mg in normotensive compared to pre-
eclamptic group with significant positive correlations between Ca and Mg across both groups. 
The levels of Se and Mn were lower in the pre-eclamptic group, with only a significant 
decrease observed in Mn (p = 0.022) levels compared to the normotensive group. A 
significant decrease in both Co (p = 0.000) and Cd (p = 0.004) concentrations was observed in 
the pre-eclamptic group. Furthermore, a positive correlation between these two trace elements 
(r = 0.846, p = 0.000) was also noted in the pre-eclamptic group. Findings from the dietary 
information revealed that the intake of cheese (p = 0.004), green vegetables (p = 0.001), fruits 
(p = 0.0001) and yoghurt (p = 0.001) were less common in the normotensive group compared 
to the pre-eclamptic. The clinical data showed strong evidence of lower baby weight in the 
pre-eclamptic pregnancies.   
 
Strengths and Limitations 
A major strength of this study is that elemental analysis of nails from pre-eclamptic women is 
novel. This study also analyzes thirteen different elements, including toxic element levels and 
recorded dietary intake data in a South African population. We however, did not investigate 
the adherence to ferrous sulphate, Ca and folic acid supplementation; neither did we take into 
consideration the population exposure to different toxic elements in the environment. In 
addition, though we found that fetal weights in the pre-eclamptic group were lower than that 
in the normotensive group, we had no information as to whether these babies had intrauterine 








During gestation the excess or deficiency of trace elements may contribute to endothelial 
dysfunction resulting in complications such as pre-eclampsia. The decreased level of Ca is 
known to lead to the constriction of smooth muscles in the blood vessels, which leads to 
increased vascular resistance and consequential blood pressure elevation. Also, low Ca levels 
may increase blood pressure by stimulating the release of parathyroid hormone and renin 
which then increases intracellular Ca in smooth muscles, resulting in vasoconstriction 
(Ephraim et al., 2014, Elind, 2016). It is mandatory practice for patients to receive Ca 
supplementation including ferrous sulphate and folic acid supplementation; however Mg 
either as a tablet or in a multivitamin preparation was not prescribed as standard care in our 
study. Our study found Co levels were reduced in the pre-eclamptic compared to the 
normotensive group. Cobalt benefits human health as it is a component of vitamin B12 and 
low levels of B12 can cause complications such as anemia, infections, inflammation and pre-
eclampsia (Huwait et al., 2015).  
 
The mechanism by which pre-eclampsia develops is linked to an increase in oxidative stress. 
Oxidative stress is defined as an imbalance between excess cellular generation of reactive 
oxygen species (ROS) and antioxidants (Ikaraoha et al., 2016, Elind, 2016). Studies have 
recorded a decrease in the production of antioxidants in pre-eclamptic women (Ikaraoha et al., 
2016, Elind, 2016). Our study found decreased levels of Cu and increased levels of Zn in the 
pre-eclamptic compared to normotensive group. Notably, Zn protects cells from free radical 
injury and is a fundamental component of the antioxidant enzyme, superoxide dismutase. 
Zinc supplementation has been shown to increase plasma antioxidant power, decrease plasma 
inflammatory cytokines and oxidative stress. Zinc is involved in the defense against oxidative 
stress and is an essential cofactor for thymulin which modulates cytokine release and induces 
proliferation (Maggini et al., 2007). Copper and Zn are the essential components of the 
antioxidant enzyme, copper-zinc superoxide dismutase which is responsible for the removal 
of free radicals (Al-Jameil et al., 2015). In our study, Mn levels were reduced in the pre-
eclamptic group; this element is an important cofactor in a wide range of antioxidant 
enzymes. This finding further implicates a possible decrease in the antioxidant levels and 
increase in oxidative stress. Recent studies have also associated low maternal blood Mn 
concentration with poor birth outcomes such as increased risk of IUGR and low birth weight 
(Wood, 2009) whereas, low Se status was associated with a greater risk of the development of 
pre-eclampsia (Rayman et al., 2014).  Our results also show reduced Se levels in the pre-
eclamptic group. A finding similar to that of Rayman et al (2003) who found significantly 
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lower (p = 0.001) median toenail Se concentrations in a pre-eclamptic group (0.56 mg/kg) 
compared to matched controls (0.62 mg/kg) (Rayman et al., 2014).  This study also observed 
that lower Se levels was significantly related to the severity of pre-eclampsia (p = 0.029) 
adjudged by delivery before 32 weeks (Rayman et al., 2014). Selenium is required for 
optimum immune response and influences the innate and acquired immune response systems. 
It plays a key role in the removal of excess damaging free radicals which are produced during 
oxidative stress (Maggini., 2007). However, not all free radicals are harmful, as nitric oxide 
(NO) is a potent vasodilator that causes relaxation of the smooth muscles. It mediates 
endothelial function by regulating vascular tone and smooth muscle cell development. In 
placenta, endothelial nitric oxide synthase (eNOS) is associated with the differentiation of 
cytotrophoblast to syncytotrophoblast.  Additionally, eNOS uncoupling has been observed to 
be a source of superoxide formation and is related to reduce NO production. Various 
inflammation modulators such as TNF-α is increased in plasma and placenta of pre-eclamptic 
women. TNF-α downregulates eNOS which leads to elevated levels of ROS and an increase 
in oxidative stress (Aranguren et al., 2014). Using a rat model, Wang et al (2014), found that 
prenatal exposure to low levels of Cd induces the phenotypical characteristics of pre-
eclampsia such as hypertension, proteinuria and IUGR. This study also showed evidence that 




This study demonstrates a significant decrease in the levels Cd, Co and Mn in pre-eclampsia. 
Therefore, increasing the dietary intake of essential nutrients may reduce the risk of pre-
eclampsia development and ensure the delivery of a healthy baby. More extensive studies on 
these elements may confirm the exact role of nutrition in the pathogenesis of pre-eclampsia. 
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Pre-eclampsia is a hypertensive disorder that is associated with adverse maternal and perinatal 
outcomes. It has been proposed that specific trace and macro elements associated with 
antioxidant activities may also play a contributory role in aetiology of pre-eclampsia. The aim 
of this study was to measure the concentrations of thirteen different elements in hair and 
serum samples from women with a diagnosis of pre-eclampsia.  Venous blood and pubic hair 
samples were collected from forty-three pre-eclamptic and twenty-three normotensive 
pregnant women. In each sample, the concentration of arsenic (As); calcium (Ca); cadmium 
(Cd); chromium (Cr); cobalt (Co); magnesium (Mg); manganese (Mn); iron (Fe); copper 
(Cu); lead (Pb); selenium (Se); nickel (Ni); zinc (Zn) were measured using inductively 
coupled plasma-optical emission spectrometry.  Cobalt concentration in hair was significantly 
lower in the pre-eclampsia group (1.56 ±0.74 µg/g) compared to the normotensive group 
(2.89 ±4.99 µg/g) (p = 0.02). The concentrations of Zn and Cr were significantly higher in 
hair samples from the pre-eclamptic group, compared to the normotensive control (Zn, 395.99 
±48.60 vs 330.88 ±29.70 µg/g; Cr, 13.31 ±2.67 vs 11.05 ±7.62 µg/g: p ≤ 0.05). There were no 
significant differences in the hair levels of other elements between groups. Serum Zn was 
significantly higher in the pre-eclamptic group (0.16 – 253.4 mg/L) compared to the 
normotensive group (0.2 – 48.4 mg/L) (p = 0.01). Serum Ca, Co, Cu, Mg, Mn and Se levels 
were found to be significantly lower in the pre-eclamptic group compared to the normotensive 
group (p < 0.05).  This study confirms the association between pre-eclampsia and maternal 
trace as well as macro element levels. 
  
Keywords: Pre-eclampsia, trace elements, macronutrients, pregnancy, hypertension, blood 












The nutritional status of women of reproductive age and during pregnancy is important for 
their own health and healthy birth outcomes [1-2]. It is well documented that pregnancy is the 
time during which increased nutrients are most needed by the mother to support fetal growth 
and development while maintaining maternal homeostasis and preparing the mother for 
lactation [3]. It is also a period of small, continuous gestation-related physiologic changes that 
affect the metabolism of all nutrients. For instance, within several weeks of conception an 
endocrine organ (placenta) is formed which secretes hormones that impacts the metabolism of 
all nutrients [3]. Thereafter, the fetus is dependent on the mother to deliver its nutrients via 
the placenta. Since the placenta carries oxygenated, nutrient-rich blood to the fetus, it is 
considered to be rich in micro-nutrient-requiring antioxidant enzymes. These include 
glutathione peroxidases (selenium) and superoxide dismutases (copper, zinc and manganese), 
which are vital for protecting the embryo and placenta from oxidative stress. Inadequate 
antioxidant activity has been postulated to be related to reduction in placental vascularization 
and blood supply to the fetus. This may potentially result in hypoxia and ischaemia, and is 
likely to contribute to pre-eclampsia and poor fetal growth [4]. Therefore, deficiencies of 
macronutrients or micronutrients can increase a women’s risk for pregnancy complications 
such as pre-eclampsia [5].   
 
Pre-eclampsia is a multi-systemic condition occurring after 20 weeks of gestation. It is 
clinically characterised by new onset hypertension (systolic blood pressure ≥140 mmHg; 
diastolic blood pressure ≥90 mmHg) and proteinuria (≥ 300 mg/24 h) [6]. Globally, pre-
eclampsia is one of the major causes of maternal and neonatal morbidity and mortality. In 
South Africa, pre-eclampsia is also the commonest direct cause of maternal deaths [7]. 
Despite continuing research, the pathogenesis of this disorder is still unclear and delivery of 
the placenta remains the only cure [6]. Presently, a large number of other studies suggest that 
nutritional factors may also play a major role in blood pressure regulation, cardiovascular 
disease, hypertension and pre-eclampsia development [8-10].  
 
Magnesium (Mg) and calcium (Ca) deficiency has been implicated as a possible cause of pre-
eclampsia [11] since its supplementation during pregnancy may reduce the incidence of high 
blood pressure, pre-eclampsia low birth weight and pre-term birth [12]. In addition, iron (Fe) 
supplements and increased Fe stores in the third trimester are associated with increased 
oxidative stress and the risk of pre-eclampsia development [13]. Other trace element 
deficiencies such as zinc (Zn), copper (Cu) and selenium (Se) have been related to various 
reproductive problems (e.g. infertility, placental abruption, premature rupture of membranes, 
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stillbirths and low birth weight) including pre-eclampsia [14]. A number of studies have 
reported on the implication of toxic metals such as lead Pb and cadmium (Cd) in pre-
eclampsia. Human exposure to excess toxic metals in the environment and a deficiency of 
bio-elements essential for antioxidant defense mechanisms causes oxidative stress, which 
leads to pre-eclampsia [15-18].  However, further epidemiological and clinical studies 
utilizing diverse biological samples in defined populations may help understand the role of 
various essential and toxic metals in pre-eclampsia. Therefore, the aim of this study was to 
evaluate the concentrations of thirteen different elements in hair and serum samples from 
women with a diagnosis of pre-eclampsia.     
 
Material and Methods 
 
Study design 
Institutional ethics approval (BE092/16) was granted by the Biomedical Research Ethics 
Committee of the University of KwaZulu-Natal and informed consent was obtained from all 
women. This study was conducted in a large urban regional hospital. The study population 
consisted of normotensive (n = 23) and pre-eclamptic (n = 63) women. Clinical and 
demographic data were recorded by a research nurse.    
 
Hair and serum sample collection  
Hair and serum samples were collected from the same women for each study group. Hair 
samples were collected from the pubic area by using a sterile shaving razor and stored in 
sterile plastic bags at room temperature. Blood was drawn from the ante-cubital vein and 
centrifuged for 10 min at 3000 rpm to extract serum.   
 
Digestion of hair and serum samples  
To each sample (0.01 g of hair or 0.5 mL of serum), 10 mL of 70% nitric acid was added and 
heated until complete digestion occurred. Thereafter, digests were diluted aqueously in a        
25 mL volumetric flask. For method validation, the certified reference material (CRM), 
lyophilised serum control for trace elements (Ref No: 8880; ClinChek®, Munich, Germany), 
was used and was reconstituted as per instruction manual and digested under the same 
conditions as the samples. All samples were transferred into polytetrafluoroethylene (PTFE) 







Elemental Analysis of samples     
Elemental analysis of digested hair and serum samples were conducted by inductively 
coupled plasma-optical emission spectrometry (ICP-OES, Optima™ 5300 DV) at different 
wavelengths for each of the analytes. Wavelength selection was based on minimum spectral 
interferences and the wavelengths selected were: As (197 nm), Ca (393 nm), Cd (227 nm), Co 
(231 nm), Cr (268 nm), Cu (325 nm), Fe (260 nm), Mg (280nm), Mn (261 nm), Ni (232 nm), 
Pb (220 nm), Se (196 nm) and Zn (214 nm). The instrument detection limits for each analyte 
was As (4.29 ppb), Cd (0.607 ppb), Co (0.346 ppb), Cr (0.744 ppb), Cu (1.41 ppb), Mn (0.095 
nm), Ni (0.839 ppb), Pb (2.21 ppb) and Se (2.54 ppb).  
 
Statistical Analysis  
The Statistical package for the Social Sciences (PASW Statistics 23, IBM Corporation, 
Cornell, New York) was used for statistical analyses. Parametric data was expressed as mean 
± standard deviation and non-parametric data expressed as median ± SEM. Statistical 
significance of the data was determined using Independent T-test and Mann-Whitney. 
Pearson correlation coefficient was used to find the relationship among various study 




Quality assurance  
The experimental values obtained for the CRM (n = 6, p = 0.05) were (in µg/L) 4.57, 7.37, 
3.85, 10.42, 61.97, 796.8, 1334, 12382, 1345 for Cd, Cr, Mn, Ni, Se, Cu, Fe, Mg and Zn; 
compared to certified value ranges (in µg/L) (3.63-5.45), (5.99-8.99), (3.81-5.71), (7.08-10.6), 
(52.9-79.3), (681-921), (1330-1790), (11200-13600) and (1120-1520). Experimental values 
compared well with certified values thereby validating the method. 
 
Clinical and demographic data  
The clinical and socio-demographic parameters of the study population are summarized in 
Table 1. The mean maternal age, weight and body mass index (BMI) of the pre-eclamptic 
group were not significantly different from those of the normotensive group (p > 0.05).  There 
were significant differences between the groups for mean diastolic blood pressure (p = 
0.0001), systolic blood pressure (p = 0.0001), proteinuria (p = 0.0001) and gestational age (p 
= 0.004). There was a statistically significant lower rate of delivery by elective cesarean 
delivery in the normotensive (22%) group compared to the pre-eclamptic (47%) group (p = 
0.05), with normal vaginal delivery being the predominant mode of delivery in both groups.  
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There were no stillbirths or maternal deaths after delivery in both groups. The pre-eclamptic 
(2.40 ±0.94 kg) group had significantly lower mean birth weight compared to the 
normotensive (3.19 ±0.39 kg) group (p = 0.004). A strong positive Pearson correlation 
coefficient was observed between BMI and maternal weight (r = 0.96, p = 0.0001); BMI and 
diastolic pressure (r = 0.5, p = 0.007) as well gestational age at delivery and baby weight (r = 
0.7, p = 0.0001) in the pre-eclamptic group.  
 




(n = 23) 
Pre-eclamptic Group 
(n = 43) 
Significance 
(P-value) 
Unemployment Rate (%) 100 81 0.04* 
Maternal Age (years) 24 ±5 25 ±5 0.36 
Maternal Weight (kg) 71 ±16 74 ±20 0.65 
BMI (kg/m2) 43 ±7 31 ±8 0.69 
Systolic Blood Pressure 
(mmHg) 
107.87 ±15.59 158.05 ±14.16 0.0001* 
Diastolic Blood Pressure 
(mmHg) 
67.91 ±11.67 103.14 ±12.23 0.0001* 
#Proteinuria (+) 0 ±0 1 ±0 0.0001* 
Gestational Age at Delivery 
(weeks) 
37 ±5 33 ±5 0.004* 
Caesarean Delivery (%) 22 47 0.05* 
Baby Weight (kg) 3.19 ±0.39 2.40 ±0.94 0.004* 
#Quantification of proteinuria using the urinary dipstick testing is as follows: 0 = 0 mg/dL; 1 = 30 to 
100 mg/dL. Abbreviations: n, number of patients; BMI, body mass index. Data are mean ± standard 
deviation. *Compared with normotensive control group, p ≤ 0.05. 
 
 
Elemental concentrations in hair  
The concentrations of 13 different elements in hair samples from both the pre-eclamptic and 
normotensive groups are shown in Table 2. Although median concentrations in hair for As, 
Ca, Cd, Fe, Mg, Pb and Se were higher in the pre-eclamptic group compared to the 
normotensive group, this was not significantly different (p > 0.05).  Median Cu, Mn and Ni 
concentrations in the hair were lower in the pre-eclamptic group compared to the 
normotensive group (p > 0.05). The median concentration of Co was significantly lower (p = 
0.02) while the median concentrations of Zn and Cr were significantly higher (p ≤ 0.05) in 




Table 2 The levels of different elements in hair samples from the pre-eclampsia and control groups (n = 
66).    
 
Normotensive Control Group 
(n = 23) 
Pre-eclamptic Group 
(n = 43) 
 
P-value 
 (µg/g) (µg/g)  
As 5.47 ±2.79 (0.06, 49.23) 7.63 ±1.32 (0.44, 19.59) 0.50 
Ca 2184.91 ±160.69 (1213.65, 4674.34) 2394.75 ±124.77 (1550.53, 4925.18) 0.12 
Cd 3.75 ±0.64 (2.78, 17.50) 3.96 ±0.87  (2.03, 34.60) 0.12 
Co 2.89 ±4.99 (0.14, 36.51) 1.56 ±0.74 (0.14, 11.32) 0.02* 
Cr 11.05 ±7.62 (3.25, 158.96) 13.31 ±2.67 (5.81, 88.08) 0.01* 
Cu 78.78 ±28.21 (1.08, 668.97) 58.87 ±17.32 (4.84, 590,98) 0.53 
Fe 449.39 ±78.36 (191, 1453.89) 613.54 ±107.29  (232.69, 4433.83) 0.20 
Mg 451.71 ±36.79 (278.02, 983.81) 549.56 ±29.34  (345.18, 1264.08) 0.08 
Mn 13.57 ±1.13 (8.20, 29.05) 13.07 ±0.95 (8.19, 32.55) 0.86 
Ni 8.40 ±1.31 (3.81, 35.64) 6.86 ±0.81 (0.79, 23.38) 0.85 
Pb 58.77 ±37.04 (33.04, 891.94) 72.27 ±19.82 (23.94, 773.97) 0.15 
Se 23.93 ±2.62 (0.30, 41.66) 24.42 ±1.78 (4.30, 45.48) 0.66 
Zn 330.88 ±29.70 (121.79, 668.70) 395.99 ±48.60 (138.85,1718.49) 0.05* 
Abbreviations: n, number of patients; As, Arsenic; Ca, Calcium; Cd, Cadmium; Cr, Chromium; Co, 
Cobalt; Mg, Magnesium; Mn, Manganese; Fe, Iron; Cu, Copper; Pb, Lead; Se, Selenium; Ni, Nickel; 
Zn, Zinc. Values are median ± SEM (minimum, maximum). * Compared with normotensive control 




Elemental concentrations in serum  
The concentrations of 13 different elements in serum samples from the pre-eclamptic and 
normotensive groups are shown in Table 3. Although serum Zn levels was significantly 
higher in the pre-eclamptic group (0.16 – 253.4 mg/L) compared to the normotensive group 
(0.2 – 48.4 mg/L) (p = 0.01), note that Zn was below the instrument detection limit for some 
measurements in each of the study groups. Serum Ca, Co, Cu, Mg, Mn and Se was 
significantly lower in the pre-eclamptic group relative to the normotensive control group (p < 
0.05). Statistically, there were no significant differences in serum As, Cd, Cr, Fe, Ni and Pb 













Table 3 Serum levels of different elements across study groups (n = 66). 
 
 
Normotensive Control Group 
(n = 23) 
 
Pre-eclamptic Group 








 (mg/L) (mg/L)  (mg/L)  
As 0.49 ±0.0 (0.01, 0.13) 0.06 ±0.0 (0.06, 0.06) 0.81 0.002-0.023 [19] 
Ca 107.61 ±6.30 (85.47, 222.34) 75.44 ±2.06 (56.58, 102.81) 0.02* 82-97# [20] 
Cd 0.10 ±0.3 (0.01, 0.34) 0.05 ±0.04 (0.01, 0.96) 0.14 0.001-0.005 [19] 
Co 0.02 ±0.0 (0.0, 0.03) ND 0.0001* <0.001 [21] 
Cr 0.05 ±0.03 (0.0, 0.24) 0.24 ±0.01 (0.0, 0.37) 0.26 < 0.0-0.0021 [19] 
Cu 5.19 ±3.09 (0.91, 58.59) 2.27 ±0.25 (0.42, 8.21) 0.001* 1.3-2.4# 
[20] 
Fe 179.94 ±47.31 (25.31, 829.83) 142.64 ±129.00 (0.99, 4891.3) 0.32 0.3-1.93# 
[20] 
Mg 38.73 ±1.44 (31.09, 61.80) 29.93 ±0.41 (24.27, 36.50) 0.0001* 11-22# 
[20] 
Mn 0.03 ±0.0 (0.0, 0.16) 0.02 ±0.0 (0.01, 0.03) 0.03* 0.004-0.012 [19] 
Ni 0.14 ±0.0 (0.0, 0.09) 0.02 ±0.0 (0.0, 0.06) 0.16 0.001-0.005 [19] 
Pb 0.16 ±0.21 (0.0, 3.0) 0.20 ±0.17 (0.04, 5.49) 0.22 <0.25 [19] 
Se 0.14 ±0.01 (0.04, 0.21) 0.06 ±0.01 (0.0, 0.16) 0.001* 0.71-1.33# 
[20] 
Zn 2.13 ±3.01 (0.20, 48.36) 18.03 ± 30.28 (0.16, 253.40) 0.01* 0.5-0.77# 
[20] 
Abbreviations: n, number of patients; ND, not detected (measurements were below the instrument 
detection limit); As, Arsenic; Ca, Calcium; Cd, Cadmium; Cr, Chromium; Co, Cobalt; Mg, 
Magnesium; Mn, Manganese; Fe, Iron; Cu, Copper; Pb, Lead; Se, Selenium; Ni, Nickel; Zn, Zinc. 
Values are median ± SEM (minimum, maximum). * Compared with the normotensive control group, p 




Correlation analysis  
Table 4 shows the correlation between selected clinical parameters (maternal and fetal) and 
hair elemental concentrations in the pre-eclampsia. A significant positive correlation between 
hair Se concentrations and gestational age at delivery (r = 0.31, p = 0.05) was found (Table 
4).  Table 5 shows strong significant positive correlations between maternal age and serum Ni 
concentrations (r = 0.45, p = 0.05); serum Ni concentrations and diastolic blood pressure (r = 
0.3, p = 0.05); maternal weight and serum Zn concentrations (r = 0.88, p = 0.05); BMI and 
serum Zn concentrations (r = 0.80, p = 0.01); as well as baby weight and serum Zn 
concentrations (r = 0.6, p = 0.6) in the pre-eclamptic group. Also, significant positive 
correlations between maternal weight and serum Cr concentrations (r = 0.33, p =0.05); BMI 
and serum Cr concentrations (r = 0.38, p =0.05); diastolic blood pressure and serum Cr 
concentrations (r = 0.34, p = 0.05) were observed in the pre-eclamptic group. Moreover, there 
were significant negative correlations between serum Ni concentrations with gestational age 
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(r = -0.5, p = 0.01) and baby weight (r = - 0.35, p = 0.05) were noticed in the pre-eclamptic 
group.      
 
Table 4 Correlations between hair elemental levels (µg/g), maternal and fetal parameters in the pre-
eclamptic group (n = 43).  
 
Parameters As Ca Cd Co Cr Cu Fe Mg Mn Ni Pb Se Zn 
Mat Age -0.23 0.29 -0.07 0.46 -0.16 0.20 -0.20 0.31 -0.03 0.07 -0.08 0.03 0.08 
Mat weight -0.06 -0.23 -0.12 0.33 -0.21 0.00 -0.16 0.06 -0.21 -0.17 -0.17 0.26 -0.26 
BMI 0.11 -0.26 -0.14 0.41 -0.11 -0.07 -0.24 0.06 -0.31 -0.06 -0.18 0.09 -0.22 
Gest Age 0.26 0.14 0.14 0.18 0.18 0.11 -0.20 0.13 0.1 -0.03 0.14 0.31* -0.01 
DBP 0.11 0.00 0.07 -0.20 -0.16 -0.12 0.07 0.10 -0.18 -0.08 0.11 -0.15 -0.19 
SBP 0.11 0.09 -0.03 0.17 -0.08 -0.02 0.25 0.01 0.04 0.04 0.01 0.0 -0.0 
Baby Weight -0.12 0.02 0.12 0.49 0.14 -0.10 0.13 -0.7 0.21 -0.25 0.12 0.30 -.051 




Table 5 Correlations between serum elemental levels (mg/l), maternal and fetal parameters in the pre-
eclamptic group (n = 43).  
Parameters As Ca Cd Co Cr Cu Fe Mg Mn Ni Pb Se Zn 
Mat Age 0.0 -0.08 -0.16 -0.03 0.01 0.04 0.08 0.02 -0.02 0.45** 0.23 -0.13 0.48 
Mat weight 0.0 0.19 -0.11 0.27 0.33* -0.08 0.17 0.12 -0.1 -0.04 -0.10 -0.09 0.88** 
BMI 0.0 0.14 -0.07 0.30 0.38* -0.15 0.16 0.09 -0.2 -0.07 -0.11 -0.16 0.80* 
Gest Age 0.0 -0.08 -0.16 -0.03 0.01 0.04 0.08 0.02 -0.02 -0.5** 0.23 -0.13 0.48 
DBP 0.0 0.30 0.18 -0.06 0.34* -0.11 -0.05 0.20 0.04 0.3* -0.18 -0.25 0.06 
SBP 0.0 0.17 0.25 -0.1 -0.24 -0.07 0.16 0.13 0.00 -0.01 -0.06 -0.04 -0.1 
Baby Weight 0.0 -0.08 -0.34 0.0* 0.05 0.03 0.19 0.05 0.11 -0.35* 0.21 0.03 0.6 
Pearson correlation (r); *Correlation is significant at the 0.05. ** Correlation is significant at the 0.01 






In this study, the median value of Zn in the hair samples was significantly higher in the pre-
eclamptic group (395.99 µg/g) compared to the normotensive control group (330.88 µg/g) (p 
= 0.05). Previous studies have reported either no statistically significant change, statistically 
significant higher or lower serum Zn levels in pre-eclamptic compared to normotensive 
pregnant women [22-27].  Elevated serum Zn levels may play an etiological role in women 
with primary hypertension. In this case, it is possible that excess serum Zn levels may cause 
an increase in intracellular Zn, which results in an increase of free Ca2+ levels in the smooth 
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muscular layer of the blood vessels with consequent elevated blood pressure [28]. In addition, 
high serum Zn levels with decreased serum Cu levels may also lead to elevation in systemic 
blood pressure in healthy individuals, because of the Zn-Cu antagonistic interactions that exist 
in the body. Therefore, this increased serum Zn and decreased serum Cu level reduces the 
activity of superoxide dismutase (SOD), which creates oxidative stress [28]. Interestingly, 
placental oxidative stress and maternal vascular dysfunction is a well-known phenomenon in 
pre-eclampsia [28]. In our study, the levels of Cu were also lower and the levels of Zn were 
higher in both hair and serum from the pre-eclamptic group compared to the normotensive 
control group.  We also found a negative correlation serum Zn and serum Cu concentrations 
(r = -0.37, p =0.37) were noted. Previous studies have also found significantly lower levels of 
Cu in serum [29-32] and hair [9, 30, 33] samples from the pre-eclamptic group compared to 
the control group. Similarly, hair and serum levels of Mn were also found to be significantly 
(p ≤ 0.05) lower in the pre-eclamptic group (13.07 ±0.95 µg/g and 0.02 ±0.0 mg/L 
respectively) in comparison to the control group (13.57 ±1.13 µg/g and 0.03 ±0.0 mg/L 
respectively). A similar study by Al-Jameil et al., (2014) reported on low serum Mn level in 
pre-eclampsia (0.072 mg/L) [29]. The current literature states that low serum Mn levels have 
a defined role in the impairment of endothelial function during pre-eclampsia [29].  Since, Mn 
is an active component of arginine, which is one of the most versatile amino acids that serve 
as a precursor for the synthesis of nitric oxide, and nitric acid is regarded as the key 
determinant of endothelial function [34-35]. It seems that the altered balance of nitric acid and 
reactive oxygen species (ROS) play a critical role in the pathogenesis of pre-eclampsia by 
causing endothelial dysfunction. Furthermore, it is known that nitric acid and ROS 
accumulates in placental tissue and pre-eclampsia is known to be cured by the removal of the 
placenta [34-35]. Also, Mn is required for the proper functioning of enzymes like SOD.  
Hence decreased levels of Mn may affect the antioxidant potential of cells by the resultant 
decreasing SOD activity as well as increased lipid peroxidation, causing an increase in blood 
pressure [29].   
 
Calcium and its relationship to pre-eclampsia have been widely explored [36]. During 
pregnancy, the Ca requirements are between 600 to 1300 mg/L per day and a deficiency of Ca 
increases the risk of pre-eclampsia development [9].  In our study, significantly low serum Ca 
levels in the pre-eclamptic group (75.44 ±2.06 mg/L) group compared to control group 
(107.61 ±6.30 mg/L) (p = 0.02) was noted. These findings confirm the findings of several 
other studies [9, 37-39].  It seems that serum levels of Ca play a role in the development of 
pre-eclampsia, as it has been observed that reduced Ca levels in the serum causes an increase 
in the amount of parathyroid hormone and renin release, which causes an increase in 
intracellular Ca in vascular smooth muscle. These events are responsible for increased 
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vascular resistance and vasoconstriction, which lead to a rise in blood pressure [9].  
Magnesium also plays a vital role in blood pressure regulation. Whilst Ca is needed for blood 
vessel contraction, Mg is needed for muscle relaxation and opening. Therefore, it is not 
surprising that reduced levels of Mg levels in the blood are associated with pre-eclampsia. 
During pregnancy, the Mg requirement is 400 mg/L per day. Lower levels of Mg in the serum 
of the pre-eclamptic group (29.93 ±0.41 mg/L) compared to the normotensive group (38.73 
±1.44 mg/L) were also noted in our study [9, 34]. These findings are in agreement with 
several studies which report that serum Mg levels are lower in pre-eclamptic pregnant women 
[9, 28, 36].  
 
Selenium is another element found to be deficient in pregnant women with pre-eclampsia.  It 
is a vital component of different seleno-enzymes, which are needed for defense against 
oxidative stress or ROS that cause damage to the endothelial cells. During gestation an 
increase of Se by 10 µg per day is required in order to maintain adequate levels (100 µg/L per 
day) of Se to support the increased Se requirements of the fetus, newborn and to prevent pre-
eclampsia [9]. Other elements that have been associated with pre-eclampsia are Co and Cr. 
Kolusari et al., (2008) reported that Co serum levels were lower in pre-eclamptic (1.27 µg/L) 
compared to normotensive (2.23 µg/L) women [40]. In contrast, another study reported slight 
increase in Co levels in hair from pre-eclamptic women (0.033 µg/g) compared to 
normotensive women (0.017 µg/g) and suggested that hair may be an active route of Co 
excretion [33]. Whereas, this study shows a decrease in Co and an increase in Cr levels in hair 
and serum samples from pre-eclamptic women.   
 
Noteworthy, in this study the hair levels of Zn were significantly higher in the pre-eclamptic 
group compared to the normotensive group, and that Ca and Cu were significantly lower. 
Concentrations of all elements studied were higher in hair samples than serum samples. This 
variability may be attributed to the factor that blood elemental analysis measures the 
components that are absorbed and temporarily circulating in the body before excretion and/or 
during storage. Whereas, hair elemental analysis reflects the elements stored in the body, 
body’s nutritional imbalances and presence of toxic metals in the body [41]. This study shows 
concentrations of elements in serum to be in decreasing order of Co > Cd > Ni ̴ Mn > As  ̴Se > 
Pb > Cr > Cu > Zn > Mg > Ca > Fe and concentrations of elements in hair to be in decreasing 
order of Co > Cd > Ni > As > Mn > Cr > Se > Cu > Pb > Zn > Mg > Fe > Ca.  
 
The strength of the current study was that it used a homogenous population of Black South 
African women, to prevent the confounding effects of ethnicity. Also, elemental analysis was 
performed on pubic hair in this study alleviating cosmetic factors of hair straightening and 
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bleaching as well as environmental factors that interfere with the endogenous content in hair. 
A limitation of this study was that parathyroid hormone levels were not measured as elevated 
serum parathyroid hormone levels could be a marker for low Ca levels. Low Ca levels have 




The present study reveals that maternal serum levels of Ca, Co, Cu, Mg, Mn and Se in pre-
eclamptic women are significantly lower than normotensive women. Similarly, significantly 
lower levels of Co were also observed in hair from pre-eclamptic women. Thus, the evidence 
in this present study corroborated an association between pre-eclampsia and essential 
elements (both macro and micro). Even though, there are a number of other studies 
demonstrating a significant association between pre-eclampsia and trace elements, further 
studies are required to determine the levels of these elements in all three trimesters of pre-
eclamptic pregnancies. Monitoring trace and macro elements may assist in understanding 
their role in the pathogenesis of pre-eclampsia, using them as biomarkers or prophylaxis 
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Synthesis and Conclusion 
 
Pre-eclampsia (PE) is a condition that can affect the mother and the fetus. In developing 
countries, PE accounts for 15-20% of maternal deaths and complicates 2-8% of all pregnancies 
(Shamsi et al., 2013). Whereas, reports from developed countries propose that 15% of preterm 
births together with perinatal mortality is 5 times more likely to occur in PE pregnancies. Despite 
major medical advances, the only known treatment intervention for PE is the delivery of the baby 
and placenta (English et al., 2015). 
 
Numerous studies on PE have suggested that this disease occurs in two stages (Hladunewich et 
al., 2007). The first stage is described by reduced perfusion linked to abnormal placentation with 
impaired trophoblast invasion and insufficient remodeling of the uterine spiral arteries. The 
second stage is the maternal systemic manifestations with combined inflammatory, metabolic, 
and thrombotic responses converging to change vascular function which can result in multi-organ 
damage (Hladunewich et al., 2007). This results in ROS and placenta oxidative stress, during 
pregnancy, delivery and the period following birth (Jain, 1986). The defective trophoblast 
invasion associated with pre-eclampsia may be a result of immune intolerance. In pre-eclampsia, 
failure of trophoblast invasion results in reduced uterine perfusion pressure and placental 
ischemia. This may induce the release pro-inflammatory cytokine with may contribute to mediate 
the endothelial damage (Maggini et al., 2007). Also, trace element deficiencies are common 
amongst pregnant women with recent findings now supporting the possibility that deficiency of 
some trace elements may make women susceptible to the development of PE (Roberts et al., 
2003). Some of these trace elements, known as essential elements (i.e. Cu and Zn), can regulate 
the balance between free radicals and antioxidants (Roberts et al., 2003).  
 
Copper is an important enzymatic antioxidant system in the body as it catalyzes the formation of 
ROS. The levels of Cu as well as Zn are reduced in PE patients (Akinloye et al., 2010, Kumru et 
al., 2003) while another study found that only Cu was statistically different as compared to the 
normotensive patients (Ugwuja et al., 2010). Also, studies have shown increased serum Zn 
concentration in PE patients compared to healthy pregnant women (Diaz et al., 2002, Harma et 
al., 2005). In our study, decreased levels of Cu as well as other important antioxidant components 
such as Se and Mn were found in the PE group. This may decrease antioxidant enzyme activity 
thereby increasing oxidative stress. Nutrients have the ability to increase or decrease the presence 
of free radicals or antioxidants thereby having a direct affect on oxidative stress. Therefore a diet 
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rich in fat could also be a contributing factor to the development of PE as lipids are 
comprehensibly involved in the generation of free radicals (Roberts et al., 2003). Recent studies 
have also associated low maternal blood Mn concentration with poor birth outcomes such as 
increased risk of IUGR and low birth weight (Wood, 2009). A study done by Rayman et al 
(2003) found significantly lower (p = 0.001) median toenail Se concentrations in a PE group 
(0.56 mg/kg) compared to matched controls (0.62 mg/kg). Our study also observed that lower Se 
levels were significantly related to the severity of PE (p = 0.029) and early delivery before 32 
weeks (Rayman et al., 2014). In another study carried by Ikaraoha et al (2016) a significantly 
lower serum level of Se (p = 0.0001), Zn (p = 0.001), Cu (p = 0.001), Co (p = 0.0001) and Mn (p 
= 0.0001) were reported (Ikaraoha et al., 2016). Also, Al-Jameil et al (2015) found significantly 
lower levels of Zn, Mg and Ca (p < 0.001) in serum samples of PE when compared to 
normotensive women (Al-Jameil et al., 2015). These results corroborate with the significantly 
decreased serum levels observed in our study. Calcium is regarded as the best studied element in 
PE its supplementation is vital to maintaining normal Ca levels during pregnancy (Roberts et al., 
2003). Low Ca intakes can lead to the development of hypertension by stimulating the release of 
parathyroid hormone and rennin. This in turn leads to an increase in intracellular Ca which results 
in vasoconstriction and vascular resistance (Spencer et al., 2015). Calcium together with Mg 
plays a crucial role in blood pressure regulation. Magnesium produces arterial relaxation and 
lowers arterial blood pressure during pregnancy. The onset of PE and progression to labour may 
be initiated by Mg. A proposed marker for women who are at a high risk for preterm delivery is 
low serum Mg levels, with Mg supplementation used as a preventative measure against preterm 
delivery (Spencer et al., 2015). Magnesium is also administered to manage and reduce the risk of 
PE during pregnancy (Roberts et al., 2003).  
 
We also reported reduced Co levels in the PE compared to the normotensive group in all three 
biological samples, while Cd levels were slightly elevated in the hair and reduced in the nail and 
serum samples. Cobalt benefits human health as it is a component of vitamin B12. Low levels of 
B12 can cause complications such as anemia, infections, inflammation and PE. A study conducted 
by Wang et al (2014), found that prenatal exposure to low levels of Cd induces the phenotypical 
characteristics of PE such as hypertension, proteinuria and IUGR. Cadmium exposure during 
pregnancy causes the synthesis of placental glucocorticoid (Wang et al., 2014b).   
 
In our study, the concentration of Fe was elevated in the hair and nails of PE women, while it was 
decreased in the serum samples. Iron is involved in the regulation of cytokine production and 
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mechanism of action, and in the activation of protein kinase C, which is essential for 
phosphorylation of factors regulating cell proliferation. In PE, vasospasms may occur resulting in 
the destruction of the red blood cells which leads to anemia and elevated serum iron levels. This 
initiates lipid peroxidation as excess iron react with free radicals of lipoproteins and the cell 
membrane. Also, increased vascular resistance, hepatic dysfunction and endothelial dysfunction 
may occur as a result of the changes in the serum activity of ferritin and transferrin induced by 
elevated Fe levels (Kandi et al., 2014).  
 
Lead levels in our study were increased in hair and serum but decreased in nail samples of the PE 
group. Lead increases oxidative stress by increasing ROS which results in hypertension. An 
increase in ROS inactivates nitric oxide (NO) which is a powerful vasodilator. Lead can 
negatively impact the sodium (Na) gradient pump thus affecting the activity of the Na/Ca 
exchanger leading to increased intracellular Ca and an increase in smooth muscle contractility. 
These findings strongly suggest that blood Pb concentrations could be a contributing factor to PE 
development (Kennedy et al., 2012). Arsenic is also, associated with a wide range of chronic 
illnesses (i.e. diabetes, vascular diseases) including hypertension disorders. In our study, the 
concentration of As was elevated, decreased and below the detection limit in the hair, serum and 
nails samples, respectively. Oxidative stress is recognized as a vital mechanism of As toxicity and 
lipid peroxidation. Furthermore, the presence of As may be the link between increase in oxidative 
stress and development of PE. In contrast, a novel study carried out by Sandoval-Carrillo et al 
(2016) demonstrated no association between As exposure and PE (Sandoval-Carrillo et al., 2016). 
Other elements that are reported to be related to PE are; Cr, phosphorus (P), chlorine (Cl) and 
fluoride (F). These elements cross can cross the placental membrane and are also associated with 
perinatal risks such as premature rupture of membranes, prematurity, low birth weight and fetal 
death (Elind, 2016). 
 
In the nails study, a significant decrease of Co (p = 0.0001), Mn (p = 0.022) and Cd (p = 0.004) 
was recorded in the PE as compared to the normotensive group. In the hair and serum study, the 
pubic hair samples yielded a significant decrease in Co (p = 0.02), Cr (p = 0.01) and Zn (p = 0.05) 
while Co (p = 0.0001), Mn (p = 0.03), Cu (p = 0.001), Ca (p = 0.02), Mg (p = 0.0001), Se (p = 
0.001) and Zn (p = 0.01) was significantly lower in the PE as compared to the normotensive 
group. Significantly decreased levels of Co were observed across all three biological samples 
whilst decreased levels of Mn were only observed in the serum and nail clippings samples of PE 
women. These differences may be attributed to the variation in the biological 
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properties/characteristics of the different samples, i.e. nails, hair and serum. The rate of nail 
growth is an indicator of the health status of an individual. The shape, discoloration and thickness 
of nails (both fingers and toe nails) can indicate signs of certain diseases. The elements present in 
nails reflect the dietary intake of an individual and provide an insight into the exposure period to 
elements. Therefore, nails carry different nutritional information compared to blood, as nails are 
ejected from the body once formed. These nail samples can be easily collected as it is non-
invasive and conveniently stored at room temperature. Nails are able to integrate trace elements 
according to dietary intake and environmental exposure over a period of time, making it a good 
indicator for nutrient related diseases and conditions (He, 2011).  
 
Nails and hair can also be analyzed to determine the concentration and exposure of heavy metals 
in different environments (Abdulrahman et al., 2012). The use of hair for trace element analysis 
allows for accuracy and repeatability while it also provides a long term exposure status 
(Abdulrahman et al., 2012). It does not deteriorate easily and the concentration of trace elements 
in this type of biological sample is at least 10 times greater than in blood and urine (Krajewski et 
al., 2009). Hair sampled from the scalp is exposed to various substances such as shampoos and 
hair dyes. This can affect the elemental concentration found in the hair (Bass et al., 2001) , 
therefore pubic hair was chosen to be used in our study. Conversely, the use of serum is an 
invasive method and may also be prone to contamination. This type of samples need to be stored 
correctly and analysis maybe be time consuming (Hambidge, 2003). 
 
In summary, the present study demonstrates that maternal serum levels of Ca, Co, Cu, Mg, Mn 
and Se in pre-eclampsia were significantly lower than normotensive women. Similarly, 
significantly lower levels of Co were observed in hair from pre-eclamptic women. A significant 
decrease in the levels Cd, Co and Mn in nails of PE women was observed. These results show an 
imbalance between macro and trace elements in PE. Therefore, more extensive studies on these 
elements may confirm the exact role of nutrition in the pathogenesis of PE and may be used as 














































Abdulrahman, F. I., Akan, J. C., Chellube, Z. M. & M.Waziri 2012. Levels Of Heavy 
Metals In Human Hair And Nail Samples From Maiduguri Metropolis, Borno State, 
Nigeria. World Environ, 2, 81-89. 
 
Ahmad, S. A., Sayed, M. H. S. U., Barua, S., Khan, M. H., Faruquee, M. H., Jalil, A., 
Hadi, S. A. & Talukder, H. K. 2001. Arsenic In Drinking Water And Pregnancy 
Outcomes. Environ Hlth Persp, 109, 629-631. 
 
Akinloye, O., Oyewalei, O. J. & Oguntibeju, O. O. 2010. Evaluation Of Trace Elements 
In Pregnant Women With Preeclampsia. 
 
Al-Jameil, N., Tabassum, H., Ali, M. N., Qadeer, M. A., Khan, F. A. & Al-Rashed, M. 
2015. Correlation Between Serum Trace Elements And Risk Of Preeclampsia: A Case 
Controlled Study In Riyadh, Saudi Arabia. Saudi J Biol Sci, 1-7. 
 
Alghazali, B. S., Sadiq, A. M. & Hasan, N. N. 2014. The Role Of Trace Elements (Zinc, 
Copper, Magnesium And Calcium) In Pregnant Women With Preeclampsia In Third 
Trimester And Fetal Cord Blood After Delivery. Muthanna Medical Journal, 1, 12-18. 
 
Allen, L. H. 2000. Anemia And Iron Deficiency: Effects On Pregnancy Outcome. Ameri 
J Clini Nutri, 71, 1280s-1284s. 
 
Amin, S. V., Illipilla, S., Hebbar, S., Rai, L., Kumar, P. & Pai, M. V. 2014. Quantifying 
Proteinuria In Hypertensive Disorders Of Pregnancy. Int J Hypertens, 8, 1-11. 
 
Awadallah, S., Abu-Elteen, K., Elkarmi, A., Quaraein, S., Salem, M. & Mubarak, M. 
2004. Maternal And Cord Blood Serum Levels Of Zinc, Copper And Iron In Healthy 




Baloch, G. H., Shaikh, K., Jaffery, M. H., Abbas, T., Das, C. M., Devrajami, B. R., Shah, 
S. Z. A. & Fazlani, K. 2012. Serum Magnesium Level During Pregnancy. World App Sci 
J 17, 1005-1008. 
 
Bartsch, E., Medcalf, K. E., Park, A. L. & Ray, J. G. 2016. Clincal Risk Factors For Pre-
Eclampsia Determined In Early Pregnancy: Systemic Review And Meta-Analysis Of 
Large Cohort Studies. Bmj, 353, 1-10. 
 
Bass, D. A., Hickok, D., Quig, D. & Urek, K. 2001. Trace Element Analysis In Hair: 
Factors Determining Accuracy, Precision, And Reliability. Altern Med Rev 6, 472-81. 
 
Dadelszen, P. V., Firoz, T., Donnay, F., Gordon, R., Hofmeyr, G. J., Lalani, S., Payne, B. 
A., Roberts, J. M., Teela, K. C., Vidler, M., Sawchuck, D. & Magee, L. A. 2012. Pre-
Eclampsia In Low And Middle Income Countries-Health Services Lessons Learned From 
The Pre-Empt(Pre-Eclampsia-Eclampsia Monitoring, Prevention & Treatment) Project. J 
Obstet Gynaecol, 34, 917-926. 
 
Dadelszen, P. V. & Magee, L. A. 2014. Pre-Eclampsia: An Update. Curr Hyptens Rep, 
16, 1-14. 
 
Diaz, E., Halhali, A., Luna, C., Diaz, L., Avila, E. & Larrea, F. 2002. Newborn Birth 
Weight Correlates With Placental Zinc, Ambilical Insulin-Like Growth Factor , And 
Leptin Levels In Pre-Eclampsia. Arch Med Res, 33, 40-47. 
E.Hassan, E., Elhhatim, W. S., M.Bakhit, S., Shrif, N. E. M. A. & A.Huneif, M. 2014. 
Assessment Of Trace Elements In Sudaneese Preeclamotic Pregnant Women. European 
Journal Of Biomedical And Pharmaceutical Sciences, 1, 13-21. 
 
Elind, A.-H. O. 2016. Trace Elements As Potential Biomarkers Of Pre-Eclampsia. Ann 
Res Rev Biol, 9, 1-10. 
 
English, F. A., Kenny, L. C. & Mccarthy, F. P. 2015. Risk Factors And Effective 




Ephraim, R. K. D., Osakunor, D. N. M., Denkyira, S. W., Eshun, H., Amoah, S. & Anto, 
E. O. 2014. Serum Calcium And Magnesium Levels In Women Presenting With Pre-
Eclampsia And Pregnancy-Induced Hypertension: A Case-Control Study In The Cape 
Coast Metropolis, Ghana. Bmc Pregnancy And Childbirth, 14, 1-8. 
 
Gambling, L., Danzeisen, R., Fosset, C., Andersen, H. S., Dunford, S., S.Srai, S. K. & 
Mcardle, H. J. 2003. Iron And Copper Interactions In Development And The Effect On 
Pregnancy Outcome. J Nutr, 133, 1554s-6s. 
 
Hacker, A. N., Fung, E. B. & King, J. C. 2012. Role Of Calcium During Pregnancy: 
Maternal And Fetal Needs. Nutr Rev, 70, 397-409. 
 
Haman, T., Mathee, A. & Swart, A. 2015. Low Levels Of Awareness Of Lead Hazards 
Among Pregnant Women In A High Risk-Johannesburg Neighourhood. Int J Environ Res 
Public Health, 12, 15022-12027. 
 
Hambidge, M. 2003. Biomarkers Of Trace Mineral Intake And Status. J Nutr, 133, 948s-
955s. 
 
Harma, M., Harma, M. & Kocyigit 2005. A Correlation Between Maternal Plasma 
Homocysteine And Zinc Levels In Pre-Eclamptic Women. Biol Trace Elem Res, 104, 97-
106. 
 
He, K. 2011. Trace Elements In Nails As Biomarkers In Clinical Research. Eur J Clin 
Invest, 41, 98-102. 
 
Hladunewich, M., Karumanchi, S. A. & Lafayette, R. 2007. Pathophysiology Of The 
Clinical Manifestations Of Pre-Ecalmpsia. Clin J Am Soc Nephrol, 2, 543-549. 
 
Huwait, E. A., Kumosani, T. A., Moselhy, S. S., Mosaoa, R. M. & S.Yaghmoor, S. 2015. 
Relationship Between Soil Cobalt And Vitamin B12 Levels In The Liver Of Livestock In 




Ikaraoha, I. C., Mbadiwe, N. C., Anetor, J. I. & Ojareva, I. A. 2016. Serum Trace 
Elements In Pre-Eclamptic Nigerians. As J Med Sci, 7, 78-83. 
 
Jain, S. 1986. Membrane Lipid Peroxidation In Erythrocytes Of The Newborn. Clin 
Chem Acta, 16, 301e6. 
 
Jeyabalan, A. 2013. Epidemiology Of Pre-Eclampsia: Impact Of Obesity Nutr Rev, 71, 1-
14. 
 
Kandi, S., T, S., Ramadevi, C., Venugopal, B., Rajkumar, R., Rafi, M. & Ramana, K. V. 
2014. Pre Eclampsia And Iron Status: A Review. American Journal Of Medical And 
Biological Research, 2, 121-123. 
 
Kennedy, D. A., Woodland, C. & Koren, G. 2012. Lead Exposure, Gestational 
Hypertension And Pre-Eclampsia: A Systematic Review Of Cause And Effect. J Obstet 
Gynaecol, 32, 512-517. 
 
Kippler, M., Tofail, F., Gardner, R., Rahman, A., Hamadani, J. D., Bottai, M. & Vahter, 
M. 2012. Maternal Cadmium Exposure During Pregnancy And Size At Birth: A 
Prospective Cohort Study. Environ Hlth Persp, 120, 284-289. 
 
Krajewski, P., Chudzik, A., Pokrzywnicka, M., Kalinka, J. & Kwiatkowska, M. 2009. 
Macro-, Micro- And Trace Elements Concentrations In Mother’s And Newborn’s Hair 
And Its Impact On Pregnancy Outcome: A Review. Archives Of Perinatal Medicine, 15, 
67-71. 
 
Kuboyama, K., Sasaki, N., Nakagome, Y. & Kataoka, M. 2005. Wet Digestion. 
Analytical Chemistry, 360, 184-191. 
 
Kumru, S., Aydin, S., Simsek, M., Sahin, K. & Yaman, M. 2003. Comparison Of Serum 
Copper, Zinc, Calcium And Magnesium Levels In Pre-Eclapmtic And Healthy Pregnant 




Madazli, R., Yuksel, M. A., Imamoglu, M., Tuten, A., Oncul, M., Aydin, B. & 
Demirayak, G. 2014. Comparison Of Clinical And Perinatal Outcomes In Early‑ And 
Late‑Onset Preeclampsia. Arch Gynecol Obstet, 290, 53-57. 
 
Maggini S, Wintergerst ES, Beveridge S & Hornig DH. 2007. Selected vitamins and 
trace elements support immune function by strengthening epithelial barriers and cellular 
and humoral immune responses. Br J Nutr, 98, S29-S35. 
Nishijo, M., Nakagawa, H., Honda, R., Tanebe, K., Saito, S., Teranishi, H., Tawara, K. & 
Wong, O. 2002. Effects Of Maternal Exposure To Cadmium On Pregnancy Outcome 
And Breast Milk. Occup Environ Med, 59, 394-397. 
 
Ozden, T. A., Gokcay, G., Cantez, M. S., Durmaz, O., Issever, H., Omer, B. & Saner, G. 
2015. Copper, Zinc And Iron Levels In Infants And Their Mothers During The First Year 
Of Life: A Prospective Study. Bmc Pediatr, 15, 1-11. 
 
Pathak, P. & Kapil, U. 2004. Role Of Trace Elements Zinc, Copper And Magnesium 
During Pregnancy And Its Outcome. Ind J Pediat, 71, 1003-1005. 
 
Pieczynska, J. & Grajeta, H. 2015. The Role Of Selenium In Human Conception And 
Pregnancy. J Trace Elem Med Biol, 29, 31-38. 
 
Rasthore, S., Gupta, A., Batra, H. S. & Rathore, R. 2011. Comparative Study Of Trace 
Elements And Serum Ceruloplasmin Level In Normal And Preeclamptic Pregnancies 
With Their Cord Blood. Biomedical Research, 22, 209-212. 
 
Rayman, M. P., Searle, E., Kelly, L., Johnsen, S., Bodman-Smith, K., Bath, S. C., Mao, J. 
& Redman, C. W. G. 2014. Effect Of Selenium On Markers Of Risk Of Pre-Eclampsia In 
Uk Pregnant Women: A Randomised, Controlled Pilot Trial. Br J Nutr, 112, 99-111. 
 
Ritchie, L. D. & King, J. C. 2000. Dietary Calcium And Pregnancy-Induced 
Hypertension: Is There A Relation? Am J Clin Nutr, 71, 1371s-4s. 
 
Roberts, J. M., Balk, J. L., Bodnar, L. M., N, J. M. B., Bergel, E. & Martinez, A. 2003. 




Sanchez-Aranguren LC, Prada CE, Riano-Medina CE & Lopez M. 2014.Endothelial 
dysfunction and and pre-eclampsia: role of oxidative stress. Front Physio, 5,1-11. 
 
Sandoval-Carrillo, A., Méndez-Hernández, E. M., Antuna-Salcido, E. I., Salas-Pacheco, 
S. M., Vázquez-Alaniz, F., Téllez-Valencia, A., Aguilar-Durán, M., Barraza-Salas, M., 
Castellanos-Juárez, F. X., La Llave-León, O. & Salas-Pacheco, J. M. 2016. Arsenic 
Exposure And Risk Of Preeclampsia In A Mexican Mestizo Population. Bmc Pregnancy 
And Childbirth, 16, 153. 
 
Sanjay G &Girija W.2014. Pre-eclampsia-Eclampsia. J Obstet Gynaecol Ind, 64(1), 4-13 
 
Shamsi, U., Saleem, S. & Nishter, N. 2013. Epidemiology And Risk Factors Of Pre-
Eclampsia; An Overview Of Observational Studies. Al Ameen J Med Sci, 6, 292-300. 
 
Spencer, B. H., Vanderlelie, J. J. & Perkins, A. V. 2015. Essentiality Of Trace Element 
Micronutrients In Human Pregnancy : A Systematic Review. J Preg Child Health, 2, 1-7. 
 
Takser, L., Lafond, J., Bouchard, M., St-Amour, G. & Mergler, D. 2004. Manganese 
Levels During Pregnancy And At Birth: Relation To Environmental Factors And 
Smoking In A Southwest Quebec Population. Environ Res, 95, 119-125. 
 
Tofail, F., Vahter, M., Hamadani, J. D., Nermell, B., Huda, S. N., Yunus, M., Rahman, 
M. & Grantham-Mcgregor, S. M. 2009. Effect Of Arsenic Exposure During Pregnancy 
On Infant Development At 7 Months In Rural Matlab, Bangladesh. Environ Hlth Persp, 
117, 288-293. 
 
Ugwuja, E. I., Ejikeme, B. N., Ugwu, N. C., Obeka, N. C., Akubugwo, E. I. & Obidoa, O. 
2010. Comparison Of Plasma Copper, Iron And Zinc Levels In Hypertensive And Non-
Hypertensive Pregnant Women In Abakaliki, South Eastern Nigeria. Pak J Nutr, 9, 1136-
1140. 
 
Uzan, J., Carbonnel, M., Piconne, O., Asmar, R. & Ayoubi, J.-M. 2011. Pre-Eclampsia: 




Wang, A., Rana, S. & Karumanchi, S. A. 2009. Preeclampsia: The Role Of Angiogenic 
Factors In Its Pathogenesis. Physiol, 24, 147-153. 
 
Wang, F., Zhang, Q., Zhang, X., Luo, S., Ye, D., Guo, Y., Chen, S. & Huang, Y. 2014a. 
Preeclampsia Induced By Cadmium In Rats Is Related To Abnormal Local 
Glucocorticoid Synthesis In Placenta. Reprod Biol Endocrinol, 12, 1-9. 
 
Wang, F., Zhang, Q., Zhang, X., Luo, S., Ye, D., Guo, Y., Chen, S. & Huang, Y. 2014b. 
Preeclampsia Induced By Cadmium In Rats Is Related To Abnormal Local 
Glucocorticoid Synthesis In Placenta. Reproductive Biology And Endocrinology, 12, 1-9. 
 
Wood, R. J. 2009. Manganese And Birth Outcome. Nutri Rev, 67, 416-420. 
 
Woods, S. E., Ghodsi, V., Engel, A., Miller, J. & James, S. 2008. Serum Chromium And 
Gestational Diabetes. Jabfm, 21, 153-157. 
 
Young, B. C., Levine, R. S. & Karumanchi, S. A. 2010. Pathogenesis Of Preeclampsia. 


























































































































Addendum 2: Biomedical Research Ethics Committee Approval 
 
 
 
 
